Association of Dexmedetomidine Use With Complete Heart Block After Transcatheter Aortic Valve Replacement: A Retrospective Single-Center Cohort Study
Journal of Cardiothoracic and Vascular Anesthesia · 2026-08 · 40 (8) · 2351-2357
DOI: 10.1053/j.jvca.2026.04.012 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2026-08. Verfasst von Eric A Fried und 4 weiteren Autor:innen. Beteiligte Einrichtung: Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: eric.fried@mountsinai.org. Hauptthemen laut MEDLINE: Dexmedetomidine, Transcatheter Aortic Valve Replacement, Heart Block, Postoperative Complications. Die Arbeit nennt 9 Literaturangaben. Gefördert von: University of Oklahoma.
Abstract (Originalsprache)
OBJECTIVES Complete heart block requiring permanent pacemaker (PPM) implantation is a known complication after transcatheter aortic valve replacement (TAVR). Dexmedetomidine (DEX) reduces postoperative delirium but is associated with hypotension, bradycardia, and conduction abnormalities. To date, DEX has not been implicated as an independent risk factor for PPM after TAVR. The authors hypothesized that intraoperative DEX use would increase PPM rates after TAVR. DESIGN Retrospective cohort study. SETTING Single center from January 1, 2019, to July 1, 2025. PARTICIPANTS Two thousand twenty-two TAVRs performed under monitored anesthesia care without pre-existing PPM were included. INTERVENTIONS None. MEASUREMENTS AND MAIN RESULTS DEX use was categorized into 4 levels: no DEX (786 patients), low dose ( 2 μg/kg, 301 patients). DEX use was not associated with PPM at any dose: low dose, odds ratio (OR) of 0.98 (95% confidence interval [CI], 0.64-1.50; p = 0.92); medium dose, OR of 0.78 (95% CI, 0.50-1.22; p = 0.28), or high dose, OR of 1.05 (95% CI, 0.61-1.82; p = 0.85). Propensity-matched analysis demonstrated no difference in PPM rates between DEX and no-DEX (9.1% v 10.2%, p = 0.61). Higher PPM rates were observed in male patients (OR, 1.89; 95% CI, 1.36-2.64; p < 0.001), dialysis patients (OR, 2.32; 95% CI, 1.11-4.86; p = 0.025), patients with high-risk preoperative electrocardiograms (OR, 2.64; 95% CI, 1.75-3.99; p < 0.001), and patients receiving self-expanding valves (OR, 2.65; 95% CI, 1.77-3.96; p < 0.001). Larger self-expanding valves (OR, 1.25; 95% CI, 1.12-1.39; p < 0.001), post-balloon dilation (OR, 1.51; 95% CI, 1.05-2.18; p = 0.028), and ventricular valve deployment increased PPM risk, while aortic deployment reduced risk (OR, 0.96; 95% CI, 0.94-0.98; p < 0.001). CONCLUSIONS DEX use during TAVR was not associated with increased risk of postprocedural PPM implantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: eric.fried@mountsinai.org.
- Icahn School of Medicine at Mount Sinai, New York, NY.
Förderung
- University of Oklahoma
Zitieren
APA
Fried, E. A., Ouyang, Y., Egorova, N. N., Tang, G. H. L., & Levin, M. A. (2026). Association of Dexmedetomidine Use With Complete Heart Block After Transcatheter Aortic Valve Replacement: A Retrospective Single-Center Cohort Study. Journal of Cardiothoracic and Vascular Anesthesia, 40(8), 2351-2357. https://doi.org/10.1053/j.jvca.2026.04.012
Vancouver
Fried EA, Ouyang Y, Egorova NN, Tang GHL, Levin MA. Association of Dexmedetomidine Use With Complete Heart Block After Transcatheter Aortic Valve Replacement: A Retrospective Single-Center Cohort Study. Journal of Cardiothoracic and Vascular Anesthesia. 2026;40(8):2351-2357. doi:10.1053/j.jvca.2026.04.012
BibTeX
@article{Fried2026,
author = {Fried, Eric A and Ouyang, Yuxia and Egorova, Natalia N and Tang, Gilbert H L and Levin, Matthew A},
title = {Association of Dexmedetomidine Use With Complete Heart Block After Transcatheter Aortic Valve Replacement: A Retrospective Single-Center Cohort Study},
journal = {Journal of Cardiothoracic and Vascular Anesthesia},
year = {2026},
volume = {40},
number = {8},
pages = {2351--2357},
doi = {10.1053/j.jvca.2026.04.012}
}
EUVIMED